http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6710909-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
filingDate 2013-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc8e3b0914f58c46c5bee5d6eeedffc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a9e23082d3a2e220ddb7b658695bd13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c31bda6ed5dbd34d2a54fcca0e5f8357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bb960035988f1fe9a241c9cdbb20e0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34889e80088684accde8d0ab16eaabb1
publicationDate 2013-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-6710909-A2
titleOfInvention New crystalline forms of the sodium salt of (4- {4- [5- (6-trifluoro-methyl-pyridin-3-yl-amino) -pyridin-2-yl] -phenyl} -cyclohexyl) -acetic acid.
abstract The present invention relates to novel crystalline forms of (4- {4- [5- (6-trifluoro-methyl-pyridin-3-i-amino) -pyridin-2-yl] -phenyl} -cyclohexyl) -acetic acid , sodium salt, and its use in the treatment or prevention of a condition or disorder associated with the activity of DGAT1 in animals, in particular in humans. It also refers to processes for the elaboration of these novel crystalline forms.
priorityDate 2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282609
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464460
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID482093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8617825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13350
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID84497
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID816464
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID325875
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8694
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID44887

Total number of triples: 40.